Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3679912019 | Hydralazine 37.5 mg and isosorbide dinitrate 20 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3679913012 | Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
108411501000001113 | Isosorbide dinitrate 20 mg and hydralazine 37.5 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing hydralazine and isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Osmotic diuretic | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Hydralazine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing hydralazine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing isosorbide dinitrate in oral dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Hydralazine | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydralazine | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance | Isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance | Isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydralazine | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydralazine | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has precise active ingredient | Isosorbide dinitrate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing nitrogen and/or nitrogen compound (product) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets